Total Body Radiation

RADIATION2 trials

Sponsors

Massachusetts General Hospital, M.D. Anderson Cancer Center

Conditions

Acute Myelogenous LeukemiaChronic Lymphocytic LeukemiaHodgkin's LymphomaLeukemiaLymphomaMultiple MyelomaNon-Hodgkin's Lymphoma

Phase 1

Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention

CompletedNCT02423915

M.D. Anderson Cancer CenterLeukemia, Lymphoma

Start: 2015-07-30End: 2020-10-06Updated: 2021-01-08

Phase 2

Reduced Intensity Double Umbilical Cord Blood Transplantation

CompletedNCT01408563

Massachusetts General HospitalAcute Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Hodgkin's Lymphoma +2

Start: 2011-12-31End: 2017-06-30Updated: 2019-01-23

Related Papers

Results of phase 1 clinical trial evaluating efficacy of 3rd party cord blood regulatory T cells for prevention of graft versus host disease.

Journal of Clinical Oncology2018-05-20

Cord Blood Regulatory T Cells for Prevention of Graft Versus Host Disease

Blood2017-12-07